Patent Waiver of COVID Vaccines and IP Law with David Gindler and Jasper Tran episode artwork

EPISODE · Mar 10, 2022 · 1H

Patent Waiver of COVID Vaccines and IP Law with David Gindler and Jasper Tran

from Emphasis Added

Emphasis Added is a podcast by the Houston Law Review. Check out this episode in video on our YouTube channel at https://www.youtube.com/channel/UCDK03FEAP2lTdm4syp02ChAOn this month's episode of Emphasis Added, I spoke with Milbank's Firmwide Head of IP,  David Gindler, and Senior Milbank IP Associate, Jasper Tran, about patent waiver of COVID vaccines and the complexities of being an IP attorney. David's background includes successfully representing clients in trials with verdicts in the hundreds of millions of dollars, negotiating complex IP license agreements, and frequently speaking on hot topics in IP law, mostly notably on topics in life-sciences and pharmaceuticals. Jasper's background includes a practice focusing on complex patent and trade secret litigation in federal courts, conducting due diligence on IP/IT agreement in multi-billion-dollar acquisitions, and authoring numerous scholarly articles on Intellectual Property for journals from law school’s such as Yale and Northwestern amongst others (link to his scholarship below). We discussed the many intricacies to researching, patenting, and manufacturing vaccines and other pharmaceuticals, why the patent waiver debate might be misguided, and the potential enforcement issues that may need to be addressed when the pandemic ends.Jasper Tran SSRN Author Page – https://papers.ssrn.com/sol3/cf_dev/AbsByAuth.cfm?per_id=2357726Season 3, Episode 10: Contents00:00 – Intro04:50 – What Makes IP Attorneys Different12:30 – Patent Basics22:25 – The Patent Waiver Debate35:00 – Enforcement of COVID Vaccine Patents45:45 – Open-Source IP During a Pandemic52:00 – Closing QuestionsFor more on the Houston Law Review, please visit houstonlawreview.orgTwitter | @HoustonLRevInstagram | @HoustonLRevFacebook | @HoustonLRevLinkedIn | The Houston Law ReviewTo get a mailing or electronic subscription to the Houston Law Review click here.  For more Emphasis Added content, follow us on Instagram and check out our video content on YouTube!

Episode metadata supplied by the publisher feed · Published Mar 10, 2022

Embed this episode

Emphasis Added is a podcast by the Houston Law Review. Check out this episode in video on our YouTube channel at https://www.youtube.com/channel/UCDK03FEAP2lTdm4syp02ChA On this month's episode of Emphasis Added, I spoke with Milbank's Firmwide Head of IP, David Gindler, and Senior Milbank IP Associate, Jasper Tran, about patent waiver of COVID vaccines and the complexities of being an IP attorney. David's background includes successfully representing clients in trials with verdicts in...

Distinct summary based on available episode metadata or transcript content.

Ready to play

Patent Waiver of COVID Vaccines and IP Law with David Gindler and Jasper Tran

0:00 1:00:54

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Emphasis Added?

This episode is 1 hour and 0 minutes long.

When was this Emphasis Added episode published?

This episode was published on March 10, 2022.

Can I download this Emphasis Added episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!